Paloma Partners’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-2,352
| Closed | -$56K | – | 1860 |
|
|
2020
Q3 | $56K | Buy |
+2,352
| New | +$56K | ﹤0.01% | 1779 |
|
|
2020
Q1 | – | Sell |
-1,133
| Closed | -$24K | – | 1665 |
|
|
2019
Q4 | $24K | Sell |
1,133
-2,077
| -65% | -$44K | ﹤0.01% | 1794 |
|
|
2019
Q3 | $60K | Buy |
+3,210
| New | +$60K | ﹤0.01% | 1540 |
|
|
2015
Q2 | – | Sell |
-1,934
| Closed | -$69K | – | 1680 |
|
|
2015
Q1 | $69K | Sell |
1,934
-3,964
| -67% | -$141K | ﹤0.01% | 1027 |
|
|
2014
Q4 | $134K | Buy |
5,898
+1,350
| +30% | +$30.7K | 0.01% | 958 |
|
|
2014
Q3 | $88K | Buy |
+4,548
| New | +$88K | ﹤0.01% | 833 |
|
|
2014
Q1 | – | Sell |
-4,576
| Closed | -$130K | – | 900 |
|
|
2013
Q4 | $130K | Sell |
4,576
-1,916
| -30% | -$54.4K | 0.01% | 925 |
|
|
2013
Q3 | $232K | Buy |
+6,492
| New | +$232K | 0.01% | 711 |
|